1 completed, 1 enrolling by invitation. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
Follow PI-2620: new trials by email Literature Review of PI-2620 trials Research Report on PI-2620
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tau PET Imaging in Opioid Use Disorder 18F-PI-2620 PET/CT - Opioid-Related Disorders | Early Phase 1 | Completed | University of Pennsylvania | 12 | 2023-09-21 | 2026-06-09 |
| Alzheimer's Disease Neuroimaging Initiative 4 Neuraceq, Amyvid, Tauvid - Mild Cognitive Impairment, Alzheimer Disease | Enrolling by invitation | University of Southern California | 1500 | 2023-06-09 | 2026-09-29 |
Pick Disease of the Brain (2) · Alzheimer Disease (1) · Cognition Disorders (1) · Cognitive Dysfunction (1) · Dementia (1) · Opioid-Related Disorders (1) · Plaque, Amyloid (1)
University of Pennsylvania (1) · University of Southern California (1)
United States (2) · Canada (1)
Ilya Nasrallah, MD, PhD (1) · Michael Weiner, MD (1) · Paul Aisen, MD (1) · Ronald Petersen, MD, PHD (1)
U19AG024904 (1)